This article has been withdrawn at the request of the editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.lfs.2018.12.047 | DOI Listing |
Am J Obstet Gynecol MFM
November 2024
Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China. Electronic address:
Objective: To assess the effectiveness and safety of low molecular weight heparins (LMWHs) on live birth rates and adverse pregnancy outcomes in individuals experiencing recurrent spontaneous abortion (RSA).
Data Sources: PubMed, Web of Science, the Cochrane Library, and Embase from database inception to July 1, 2024.
Study Eligibility Criteria: Eligible randomised controlled trials enrolled women with RSA who received LMWH, with a follow-up duration of at least 12 weeks.
Trials
November 2024
Glasgow Caledonian University, Glasgow, Scotland, UK.
Background: Participant non-response is a source of bias in all research, especially in randomised controlled trials. Participants followed up remotely can have high non-response rates. Four such trials have been conducted of a cover letter with content informed by behaviour change theory to overcome hypothesised barriers to responding to a mailed questionnaire.
View Article and Find Full Text PDFSupport Care Cancer
August 2024
Xiangya Nursing School, Central South University, Changsha, Hunan, China.
World J Gastroenterol
July 2024
Gastroenterology and Digestive Endoscopy Unit, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari, Trento 38122, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!